Year: 2026
Type: preprint
Abstract: Background Multiple myeloma (MM) is characterized by marked biological and genomic heterogeneity that may influence the activity of post-transcriptional regulatory networks. We previously identified SOX4 as a contributor to MM progression. Here, we investigated the functional activity of its post-transcriptional regulator miR-335 in primary patient-derived plasma cells and assessed whether disease stage, baseline SOX4 expression, and cytogenetic background influence miR-335 responsiveness. Methods Primary CD138 + plasma cells were isolated from bone marrow aspirates of 93 patients with MGUS/SMM (n = 11), newly diagnosed MM (ND-MM; n = 29), or treated MM (T-MM; n = 53). Each sample was divided into matched Sham-control and miR-335-transfected fractions. SOX4 modulation was evaluated by RT-qPCR and confirmed at protein level in representative samples. Responses were analyzed according to baseline SOX4 and CD56 expression, ploidy, and chromosome 1q status. miR-335 activity was independently assessed through SOX4/SPP1 concordance in 45 samples, while functional and morphological effects were evaluated in primary MM cultures. Results Baseline SOX4 expression increased with disease progression and was highest in T-MM. miR-335 significantly reduced SOX4 expression in T-MM, with the strongest response in samples with high baseline SOX4 expression (median miR-335/Sham ratio 0.47 versus 0.90 in SOX4-low T-MM; p < 0.01). SOX4 and SPP1 modulation were strongly concordant in the validation cohort (R²=0.74), while ACTB remained stable. Responsiveness was associated with CD56 expression and cytogenetic background: T-MM CD56-positive samples showed greater SOX4 suppression than CD56-negative samples, while euploid and chromosome 1q non-amplified T-MM cases were more responsive than their respective counterparts. miR-335 also reduced residual cell numbers in both ND-MM and T-MM cultures (p < 0.01). Notably, therapy-conditioned cells developed rosette-like multicellular aggregates following miR-335 exposure, suggesting a distinct adaptive phenotype associated with altered adhesion and microenvironment-related signaling. Conclusions miR-335 responsiveness in primary MM cells is shaped by disease stage, baseline SOX4 expression, cellular phenotype, and cytogenetic background. These findings identify a functionally responsive, therapy-conditioned MM subset and support a patient-stratified framework for investigating miR-335-based therapeutic strategies.
Source: Research Square
Authors: Elisabetta Lombardi(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft), Riccardo Mezzetti(Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft), Francesco Agostini(Formal analysis, Methodology, Writing – original draft), Marco Valvasori(Investigation), Kevin Rossi(Visualization), Matteo Valoppi(Visualization), Rosanna Ciancia(Resources), Chiara Cigana(Resources), Barbara Montante(Resources), Silvia Crestani(Resources), Maurizio Rupolo(Resources), Iris Scapinello, Joanna Dorota Barchanowska, Gonzalo Almanza, Roberto Vettori, Mario Mazzucato(Formal analysis), Maurizio Zanetti(Conceptualization, Supervision, Writing – review & editing), Mariagrazia Michieli
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7236238343
